Cargando…
High-Throughput mRNA Sequencing Reveals Potential Therapeutic Targets of Febuxostat in Secondary Injury After Intracerebral Hemorrhage
Febuxostat is a urate-lowering medication for the treatment of patients with gout. This study was performed to elucidate the effects and underlying mechanisms of febuxostat on neuronal injury induced by intracerebral hemorrhage (ICH) in mice. The results showed that the administration of febuxostat...
Autores principales: | Wang, Xueyan, Zhang, Chenyu, Li, Yuwen, Xu, Ting, Xiang, Jin, Bai, Yang, Zhang, Ying, Wang, Qi, Zhang, Tiejun, Liao, Linchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260037/ https://www.ncbi.nlm.nih.gov/pubmed/35814252 http://dx.doi.org/10.3389/fphar.2022.833805 |
Ejemplares similares
-
Baicalin Inhibits Ferroptosis in Intracerebral Hemorrhage
por: Duan, Lining, et al.
Publicado: (2021) -
Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System
por: Bai, Yang, et al.
Publicado: (2023) -
Herb Formula (GCis) Prevents Pulmonary Infection Secondary to Intracerebral Hemorrhage by Enhancing Peripheral Immunity and Intestinal Mucosal Immune Barrier
por: Miao, Yulu, et al.
Publicado: (2022) -
Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage
por: Shao, Zhiwei, et al.
Publicado: (2019) -
Anti-oxidant effects of cannabidiol relevant to intracerebral hemorrhage
por: Yan, Gaili, et al.
Publicado: (2023)